225
Participants
Start Date
May 12, 2022
Primary Completion Date
June 30, 2025
Study Completion Date
June 30, 2025
Piromelatine 20 mg
Tablets
Placebo
Tablets
New York University School of Medicine, New York
Integrative Clinical Trials LLC, Brooklyn
AMC Research, LLC, Matthews
K2 Medical Research The Villages, Lady Lake
Interspond, LLC,, Orlando
Velocity Clinical Research, Inc, Hallandale
Verus Clinical research Corp, Miami
BioMed Research Institute, Inc., Miami
CCM Clinical Research Group, LLC, Miami
Linfritz Research Institute Inc., Coral Gables
Advance Medical Research Center, Miami
Allied Biomedical Research Institute (Clinical Trials), Miami
Vitae Research Center LLC., Miami
Stein Gerontological Institute, Inc., Miami
Miami Dade Medical Research Institute, Miami
Alzheimer's Research and Treatment Center, Wellington
Finlay Medical Research Corp., Greenacres City
The University of South Florida Board of Trustees,, Tampa
K2 Medical Research Winter Garden, Ocoee
Neurology Clinic, P.C., Cordova
Froedtert & Medical College of Wisconsin, Milwaukee
The Mile High Research Center, Denver
Velocity Clinical Research, Inc, Meridian
Collaborative Neuroscience Research, LLC, Long Beach
Asclepes Research Centers, P.C. Dba Alliance Research, Long Beach
Pacific Research Network, LLC, San Diego
ATP Clinical Research, Costa Mesa
RAA Apex Acquisition LLC DBA Syrentis Clinical Research, Santa Ana
Northwest Clinical Research Center, Bellevue
Ocean Medical Research, Jersey City
Advanced Memory Research Institute of New Jersey, Toms River
Rhode Island mood and memory research institute, Island Park
Centricity Research Halifax Multispecialty, Nova Scotia
Bluewater Clinical Research Group Inc, Sarnia
LMC Clinical Research Inc. d.b.a. Centricity Research, Toronto
OCT Research ULC (dba Okanagan Clinical Trials), Kelowna
Medical Arts Health Research Group, Vancouver
Lead Sponsor
Collaborators (1)
Syneos Health
OTHER
Neurim Pharmaceuticals Ltd.
INDUSTRY